Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Organogenesis Hldgs Q4 2023 GAAP EPS $0.010, Inline, Sales $99.651M Miss $109.050M Estimate

Author: Benzinga Newsdesk | February 29, 2024 05:13pm
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.010 per share which met the analyst consensus estimate. The company reported quarterly sales of $99.651 million which missed the analyst consensus estimate of $109.050 million by 8.62 percent. This is a 13.73 percent decrease over sales of $115.516 million the same period last year.

Posted In: ORGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist